UNAIDS estimates that under two-thirds (64%) of women living with HIV in Asia Pacific receive treatment to prevent ...

A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho ...

Spending cuts in HIV prevention that the administration is considering will lead to a surge in the deadly disease, Democratic ...

The Aliveness Project in south Minneapolis says its free HIV testing and prevention work could be in jeopardy after the Trump ...

President Donald Trump’s administration is considering gettign rid of the Center for Disease Control and Prevention’s ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

(1 Trusted Source HIV weakens the immune system by attacking infection-fighting cells. While antiretroviral therapy controls the virus, it doesn’t cure it. Mount Sinai researchers ...

Weight trajectories differed significantly among patients with HIV during the first year of ART, with no associations observed between weight gain and type of ART regimen.

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

Granada Reports Journalist Lauren Ostridge takes a look at the history of George House Trust and speaks to those it has helped. It's 40 years since George House Trust was set up in a small office ...

The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...

3TC: Lamivudine; ABC: Abacavir; DRV: Darunavir; DTG: Dolutegravir; EFV: Efavirenz; FTC: Emtricitabine; rtv: Ritonavir; TDF: Tenofovir. ↓: Decrease; ↑: Increase ...